Jad Chahoud, MD

Jad Chahoud, MD, Moffitt Cancer Center

Articles by Jad Chahoud, MD

First-Line Zanzalintinib in Combination With Checkpoint Inhibitors for the Treatment of Patients With Untreated ccRCC

Jad Chahoud, MDAdvanced Renal Cell Carcinoma | June 4, 2025

Dr. Chahoud talks about the results of the expansion cohort of the phase 1b STELLAR-002 study.